Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Niagen Bioscience (NAGE) Receivables - Other (2017 - 2023)

Niagen Bioscience (NAGE) has disclosed Receivables - Other for 8 consecutive years, with $3.5 million as the latest value for Q1 2023.

  • Quarterly Receivables - Other rose 52.17% to $3.5 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Mar 2023, up 52.17% year-over-year, with the annual reading at $3.1 million for FY2022, 47.62% up from the prior year.
  • Receivables - Other for Q1 2023 was $3.5 million at Niagen Bioscience, up from $3.1 million in the prior quarter.
  • The five-year high for Receivables - Other was $3.5 million in Q1 2023, with the low at $800000.0 in Q4 2019.
  • Average Receivables - Other over 5 years is $1.7 million, with a median of $1.6 million recorded in 2019.
  • The sharpest move saw Receivables - Other surged 171.43% in 2019, then tumbled 47.37% in 2020.
  • Over 5 years, Receivables - Other stood at $800000.0 in 2019, then rose by 12.5% to $900000.0 in 2020, then skyrocketed by 133.33% to $2.1 million in 2021, then soared by 47.62% to $3.1 million in 2022, then increased by 12.9% to $3.5 million in 2023.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $3.5 million, $3.1 million, and $2.4 million for Q1 2023, Q4 2022, and Q3 2022 respectively.